Survey of cytotoxic contamination within a reconstitution unit

S. Nussbaumer1,2,3, M. Mattiuzzo1, L. Geiser3, F. Sadeghipour1, S. Fleury-Souverain1, P. Bonnabry1,2 1 Pharmacie des Hôpitaux Universitaire de Genève (HUG),
2 Section des sciences pharmaceutiques, Université de Genève, Université de Lausanne,
3 Swiss Centre for Applied Human Toxicology, Genève, Suisse

Objective
This work’s goal was to provide an overview on the state of cytotoxic contamination within a reconstitution unit so as to highlight critical contamination areas.

Method
A surface sampling procedure combined with an LC-MS/MS method allowing for 10 cytotoxic substances (cytarabin, gemcitabin, methotrexate, phosphate etoposide, ifosfamide, cyclophosphamide, irinotecan, doxorubicin, epirubicin and vincristine) to be determined simultaneously was used. Its quantitative performances were clearly defined in terms of productivity and accuracy according to the compound and the surface tested (Anal. Bioanal. Chem. 398 (2010) 3033-3042; Anal. Bioanal. Chem. in press, DOI 10.1007/s00216-011-5157-2).

Results
About 100 samplings were made in the production area and in the cytotoxics logistics management area. The most heavily contaminated locations were inside the isolators. In the logistics room, only a few traces of cytotoxic substances were detected.

Discussion forum

GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy

Access forum

GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data